Search Within

Neha Sanat Korde

Formats
  1. Meeting Abstract (150)
  2. Journal Article (63)
  3. Research Letter (7)
  4. Review (3)
  5. Correspondence (2)
  6. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (226)
  2. Department of Medicine (226)
  3. Hematologic Malignancies, Division of (226)
  4. Myeloma (226)
  5. Survivorship Research (226)
  6. Hematologic Malignancies Research (205)

More Groups

People
  1. Sham Mailankody (181)
  2. Alexander Lesokhin (162)
  3. Hani Hassoun (157)
  4. Malin Hultcrantz (145)
  5. Sergio Giralt (138)
  6. Heather Landau (137)

More People

Years
  1. 2025 (2)
  2. 2024 (36)
  3. 2023 (40)
  4. 2022 (34)
  5. 2021 (15)
  6. 2020 (14)

More Years

Publications
  1. Blood (83)
  2. Clinical Lymphoma, Myeloma and Leukemia (47)
  3. Journal of Clinical Oncology (17)
  4. Leukemia and Lymphoma (11)
  5. Biology of Blood and Marrow Transplantation (7)
  6. Blood Cancer Journal (7)

More Publications

Publishers
  1. American Society of Hematology (89)
  2. Elsevier Inc. (60)
  3. American Society of Clinical Oncology (17)
  4. Nature Publishing Group (13)
  5. Taylor & Francis Group (11)
  6. Ferrata Storti Foundation (7)

More Publishers

Results (226)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
    Journal Article

    Lendvai, N.; Tsakos, I.; Devlin, S. M.; Schaffer, W. L.; Hassoun, H.; Lesokhin, A. M.; Landau, H.; Korde, N.; Mailankody, S.; Smith, E.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Host-related immunodeficiency in the development of multiple myeloma
    Journal Article

    Dosani, T.; Mailankody, S.; Korde, N.; Manasanch, E.; Bhutani, M.; Tageja, N.; Roschewski, M.; Kwok, M.; Kazandjian, D.; Costello, R.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
    Journal Article

    Murata, K.; McCash, S. I.; Carroll, B.; Lesokhin, A. M.; Hassoun, H.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Landau, H. J.; Koehne, G.; more...
    Clinical Biochemistry (2018)

    Fulltext@MSK | Save
  • Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma
    Journal Article

    Salem, D. A. R.; Korde, N.; Venzon, D. J.; Liewehr, D. J.; Maric, I.; Calvo, K. R.; Braylan, R.; Tembhare, P. R.; Yuan, C. M.; Landgren, C. O.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: A population-based study
    Journal Article

    Thordardottir, M.; Lindqvist, E. K.; Lund, S. H.; Costello, R.; Burton, D.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; Launer, L. J.; Gudnason, V.; more...
    Blood Advances (2017)

    Fulltext@MSK | Save
  • Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12 372 individuals 10-49 years old: A population-based study from the National Health and Nutrition Examination Survey
    Journal Article

    Landgren, O.; Graubard, B. I.; Kumar, S.; Kyle, R. A.; Katzmann, J. A.; Murata, K.; Costello, R.; Dispenzieri, A.; Caporaso, N.; Mailankody, S.; more...
    Blood Cancer Journal (2017)

    Fulltext@MSK | Save